Tanja Obradovic, Oncology Medical Strategy Adviser, Clinical Drug Development Expert, shared a post on LinkedIn:
“Glad to share publication about latest AI impact upon Phama and Biotech.
Gratitude for valuable contribution to my outstanding collaborator XiaoMai Zhang from innovative HopeAI team focusing on next generation AI applications in improving efficiency and critical decision making in clinical drug development.”
More posts about AI.